Breast lumps primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{S.M}} | {{CMG}} {{AE}} {{S.M}} | ||
Benign breast lesions require great attention regarding its influence on patient's quality of life, high prevalence and potential chance of becoming malignant<ref>Goehring, | Benign breast lesions require great attention regarding its influence on patient's quality of life, high prevalence and potential chance of becoming malignant<ref name="pmid9494790">{{cite journal| author=Goehring C, Morabia A| title=Epidemiology of benign breast disease, with special attention to histologic types. | journal=Epidemiol Rev | year= 1997 | volume= 19 | issue= 2 | pages= 310-27 | pmid=9494790 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9494790 }} </ref> | ||
*Prevention considers as the first way to decrease incidence of new cases of breast cancer rather than controlling it<ref name="pmid23539594">{{cite journal| author=Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW| title=Cancer genome landscapes. | journal=Science | year= 2013 | volume= 339 | issue= 6127 | pages= 1546-58 | pmid=23539594 | doi=10.1126/science.1235122 | pmc=3749880 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23539594 }} </ref> | |||
*Prevention of breast disease can be associated with establishing modifiable risk factors | |||
**Premenopausal women | |||
***Alcohol intake | |||
****No alcohol intake for youth aged 12-17 years, 20-30% possible risk reduction, 10-20 years until benefit<ref name="pmid22492774">{{cite journal| author=Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ et al.| title=Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. | journal=Pediatrics | year= 2012 | volume= 129 | issue= 5 | pages= e1192-8 | pmid=22492774 | doi=10.1542/peds.2011-2601 | pmc=3866773 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22492774 }} </ref><ref name="pmid23985142">{{cite journal| author=Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ et al.| title=Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. | journal=J Natl Cancer Inst | year= 2013 | volume= 105 | issue= 20 | pages= 1571-8 | pmid=23985142 | doi=10.1093/jnci/djt213 | pmc=3797023 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23985142 }} </ref> | |||
****≤1 serving/day alcohol intake for young adults 18-24 years, 20-30% possible risk reduction, 10-20 years until benefit<ref name="pmid23985142">{{cite journal| author=Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ et al.| title=Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. | journal=J Natl Cancer Inst | year= 2013 | volume= 105 | issue= 20 | pages= 1571-8 | pmid=23985142 | doi=10.1093/jnci/djt213 | pmc=3797023 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23985142 }} </ref> | |||
****≤1 serving/day alcohol intake for adults ≥18 years, 35% possible risk reduction, 10-20 years until benefit<ref name="pmid22045766">{{cite journal| author=Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC| title=Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. | journal=JAMA | year= 2011 | volume= 306 | issue= 17 | pages= 1884-90 | pmid=22045766 | doi=10.1001/jama.2011.1590 | pmc=3292347 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22045766 }} </ref><ref name="pmid9480365">{{cite journal| author=Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA et al.| title=Alcohol and breast cancer in women: a pooled analysis of cohort studies. | journal=JAMA | year= 1998 | volume= 279 | issue= 7 | pages= 535-40 | pmid=9480365 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9480365 }} </ref> | |||
***Healthy weight | |||
****Avoid weight gain in all women, 50% risk reduction after menopause, 10-30 years until benefit<ref name="pmid16835425">{{cite journal| author=Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE| title=Adult weight change and risk of postmenopausal breast cancer. | journal=JAMA | year= 2006 | volume= 296 | issue= 2 | pages= 193-201 | pmid=16835425 | doi=10.1001/jama.296.2.193 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16835425 }} </ref> | |||
***Physical activity | |||
****≥ 30min/day, forinactive women, 20% risk reduction, 10-30 years until benefit<ref name="pmid16288120">{{cite journal| author=Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D et al.| title=Lifetime recreational exercise activity and breast cancer risk among black women and white women. | journal=J Natl Cancer Inst | year= 2005 | volume= 97 | issue= 22 | pages= 1671-9 | pmid=16288120 | doi=10.1093/jnci/dji374 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16288120 }} </ref> | |||
***Healthy diet | |||
****Such as fruit, vegetables, whole grains,20-50% risk reduction, 5-20 years until benefit<ref name="pmid23349252">{{cite journal| author=Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA et al.| title=Fruit and vegetable intake and risk of breast cancer by hormone receptor status. | journal=J Natl Cancer Inst | year= 2013 | volume= 105 | issue= 3 | pages= 219-36 | pmid=23349252 | doi=10.1093/jnci/djs635 | pmc=3593764 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23349252 }} </ref><ref name="pmid19318430">{{cite journal| author=Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN et al.| title=Childhood soy intake and breast cancer risk in Asian American women. | journal=Cancer Epidemiol Biomarkers Prev | year= 2009 | volume= 18 | issue= 4 | pages= 1050-9 | pmid=19318430 | doi=10.1158/1055-9965.EPI-08-0405 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19318430 }} </ref> | |||
***Breast feeding | |||
****1 years total across all children for women who have given birth, 18% risk reduction,5 years until benefit<ref name="pmid12133652">{{cite journal| author=Collaborative Group on Hormonal Factors in Breast Cancer| title=Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. | journal=Lancet | year= 2002 | volume= 360 | issue= 9328 | pages= 187-95 | pmid=12133652 | doi=10.1016/S0140-6736(02)09454-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12133652 }} </ref> | |||
***Prophylactic bilateral oophorectomy | |||
****For carriers of BRCA 1 and 2,50% resik reduction, ≥ 2years until benefit<ref name="pmid19141781">{{cite journal| author=Rebbeck TR, Kauff ND, Domchek SM| title=Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. | journal=J Natl Cancer Inst | year= 2009 | volume= 101 | issue= 2 | pages= 80-7 | pmid=19141781 | doi=10.1093/jnci/djn442 | pmc=2639318 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19141781 }} </ref> | |||
***Tamoxifen | |||
****High risk women aged ≥35 years , 50% risk reduction,2 years until benefit <ref>Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol K. Redmond, Maureen Kavanah, Walter M. Cronin, Victor Vogel, André Robidoux, Nikolay Dimitrov, James Atkins, Mary Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators; Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, JNCI: Journal of the National Cancer Institute, Volume 90, Issue 18, 16 September 1998, Pages 1371–1388, https://doi.org/10.1093/jnci/90.18.1371</ref> | |||
**Postmenopausal women | |||
***Alcohol intake | |||
****≤1 serving/d,35% risk reduction, 5-10 years until benefit | |||
***Healthy weight | |||
****Weight loss | |||
***For overweight and obese women> 145 lbs,50% risk reduction,2-5 years until benefit | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:37, 19 December 2018
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps primary prevention On the Web |
|
American Roentgen Ray Society Images of Breast lumps primary prevention |
|
Risk calculators and risk factors for Breast lumps primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Benign breast lesions require great attention regarding its influence on patient's quality of life, high prevalence and potential chance of becoming malignant[1]
- Prevention considers as the first way to decrease incidence of new cases of breast cancer rather than controlling it[2]
- Prevention of breast disease can be associated with establishing modifiable risk factors
- Premenopausal women
- Alcohol intake
- No alcohol intake for youth aged 12-17 years, 20-30% possible risk reduction, 10-20 years until benefit[3][4]
- ≤1 serving/day alcohol intake for young adults 18-24 years, 20-30% possible risk reduction, 10-20 years until benefit[4]
- ≤1 serving/day alcohol intake for adults ≥18 years, 35% possible risk reduction, 10-20 years until benefit[5][6]
- Healthy weight
- Avoid weight gain in all women, 50% risk reduction after menopause, 10-30 years until benefit[7]
- Physical activity
- ≥ 30min/day, forinactive women, 20% risk reduction, 10-30 years until benefit[8]
- Healthy diet
- Breast feeding
- 1 years total across all children for women who have given birth, 18% risk reduction,5 years until benefit[11]
- Prophylactic bilateral oophorectomy
- For carriers of BRCA 1 and 2,50% resik reduction, ≥ 2years until benefit[12]
- Tamoxifen
- High risk women aged ≥35 years , 50% risk reduction,2 years until benefit [13]
- Alcohol intake
- Postmenopausal women
- Alcohol intake
- ≤1 serving/d,35% risk reduction, 5-10 years until benefit
- Healthy weight
- Weight loss
- For overweight and obese women> 145 lbs,50% risk reduction,2-5 years until benefit
- Alcohol intake
- Premenopausal women
References
- ↑ Goehring C, Morabia A (1997). "Epidemiology of benign breast disease, with special attention to histologic types". Epidemiol Rev. 19 (2): 310–27. PMID 9494790.
- ↑ Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (2013). "Cancer genome landscapes". Science. 339 (6127): 1546–58. doi:10.1126/science.1235122. PMC 3749880. PMID 23539594.
- ↑ Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ; et al. (2012). "Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease". Pediatrics. 129 (5): e1192–8. doi:10.1542/peds.2011-2601. PMC 3866773. PMID 22492774.
- ↑ 4.0 4.1 Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ; et al. (2013). "Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk". J Natl Cancer Inst. 105 (20): 1571–8. doi:10.1093/jnci/djt213. PMC 3797023. PMID 23985142.
- ↑ Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC (2011). "Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk". JAMA. 306 (17): 1884–90. doi:10.1001/jama.2011.1590. PMC 3292347. PMID 22045766.
- ↑ Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA; et al. (1998). "Alcohol and breast cancer in women: a pooled analysis of cohort studies". JAMA. 279 (7): 535–40. PMID 9480365.
- ↑ Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006). "Adult weight change and risk of postmenopausal breast cancer". JAMA. 296 (2): 193–201. doi:10.1001/jama.296.2.193. PMID 16835425.
- ↑ Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D; et al. (2005). "Lifetime recreational exercise activity and breast cancer risk among black women and white women". J Natl Cancer Inst. 97 (22): 1671–9. doi:10.1093/jnci/dji374. PMID 16288120.
- ↑ Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA; et al. (2013). "Fruit and vegetable intake and risk of breast cancer by hormone receptor status". J Natl Cancer Inst. 105 (3): 219–36. doi:10.1093/jnci/djs635. PMC 3593764. PMID 23349252.
- ↑ Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN; et al. (2009). "Childhood soy intake and breast cancer risk in Asian American women". Cancer Epidemiol Biomarkers Prev. 18 (4): 1050–9. doi:10.1158/1055-9965.EPI-08-0405. PMID 19318430.
- ↑ Collaborative Group on Hormonal Factors in Breast Cancer (2002). "Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease". Lancet. 360 (9328): 187–95. doi:10.1016/S0140-6736(02)09454-0. PMID 12133652.
- ↑ Rebbeck TR, Kauff ND, Domchek SM (2009). "Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers". J Natl Cancer Inst. 101 (2): 80–7. doi:10.1093/jnci/djn442. PMC 2639318. PMID 19141781.
- ↑ Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol K. Redmond, Maureen Kavanah, Walter M. Cronin, Victor Vogel, André Robidoux, Nikolay Dimitrov, James Atkins, Mary Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators; Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, JNCI: Journal of the National Cancer Institute, Volume 90, Issue 18, 16 September 1998, Pages 1371–1388, https://doi.org/10.1093/jnci/90.18.1371